JAMES R MCNAB

CIK 1190126 · last filed 2022-01-28

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$411.0K

Companies

2

Total Filings

37

Lifetime Open-Market Net

-$3.04M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
TITAN PHARMACEUTICALS INC (TTNP) Delisted Director 52,690 $4.61 $242.9K $242.3K 9 2022-01-28
CRIS Director 975,964 $0.42 $411.0K -$3.29M 27 2017-05-05

Recent Filings · Page 2 of 4

37 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2017-04-24 CRIS Sell (S) −110,322 -$285.7K EDGAR
2017-03-02 CRIS Grant (A) $0 EDGAR
2017-02-21 TITAN PHARMACEUTICALS INC (TTNP) Delisted Grant (A) $0 EDGAR
2016-05-31 TITAN PHARMACEUTICALS INC (TTNP) Delisted Buy (P) +20,000 $140.6K EDGAR
2016-01-21 CRIS Grant (A) $0 EDGAR
2016-01-14 TITAN PHARMACEUTICALS INC (TTNP) Delisted Buy (P) +16,363 $51.7K EDGAR
2015-12-16 TITAN PHARMACEUTICALS INC (TTNP) Delisted Grant (A) $0 EDGAR
2015-03-18 Grant (A) $0
2015-01-28 CRIS Grant (A) $0 EDGAR
2014-01-28 CRIS Grant (A) $0 EDGAR
Showing 1120 of 37
Page 2 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.